Exposure to CFTR Modulators During Pregnancy in Cystic Fibrosis: Four Cases to Highlight Neonatal Diagnostic Challenges and Outcomes. [PDF]
Int J Neonatal ScreenDomenach L +11 more
europepmc +1 more source
CFTR modulators partially restore the epithelial interferome in Aspergillus infection to improve clinical outcome. [PDF]
EBioMedicineLaverty SL +7 more
europepmc +1 more source
Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis. [PDF]
J Pers MedAalbers BL +6 more
europepmc +1 more source
Beyond the Surface: Novel Therapy Approach for Pancreatitis in the Setting of CFTR Dysfunction. [PDF]
Case Rep Gastrointest MedWright BA +3 more
europepmc +1 more source
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I <i>CFTR</i> variants. [PDF]
Eur Respir JDrai C +8 more
europepmc +1 more source
Analysis of the Genome Aggregation Database (gnomAD) reveals a global burden of cystic fibrosis and the need for improved diagnosis and care. [PDF]
EBioMedicineBar L, Darrah RJ, Vaidyanathan S.
europepmc +1 more source
Beyond BMI: Nutritional Recovery and Functional Implications of CFTR Modulators in Cystic Fibrosis. [PDF]
Biology (Basel)Linguiti G +6 more
europepmc +1 more source
Don't Stress: We're One Step Closer to Host-Directed Therapy for Influenza. [PDF]
Am J Respir Cell Mol BiolHook JL.
europepmc +1 more source
Beyond the mutations: spatiotemporal regulation of CFTR by cAMP and calcium signaling in epithelial physiology and cystic fibrosis. [PDF]
Cell Mol Biol LettVarga A +5 more
europepmc +1 more source